Robert E. Hoffman
Chief Executive Officer, CytoDyn Inc. · United States
Robert E. Hoffman is the CEO of CytoDyn Inc. (CYDY). Hoffman is based in the United States.
Robert E. Hoffman is an industry veteran with more than 30 years of financial and leadership experience in biotechnology. He joined CytoDyn as Chief Financial Officer in May 2025 before being appointed Chief Executive Officer in October 2026. Previously, he served as President, CEO, and interim Chief Financial Officer of Kintara Therapeutics, and held senior financial positions at Heron Therapeutics, AnaptysBio, and Arena Pharmaceuticals.
Recent developments
AI summary of recent coverageRecent coverage has focused on Robert E. Hoffman's appointment as Chief Executive Officer of CytoDyn Inc., alongside the company's highlighting of early CLOVER trial data. Reports indicate the former chief executive will continue overseeing the company's cancer-treatment initiatives as the organization advances its leronlimab development program.
Summarized from the headlines below; see each source for the full story.
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Robert E. Hoffman, it will appear here — and tie into the news timeline.
Robert E. Hoffman: FAQ
- Who is Robert E. Hoffman?
- Robert E. Hoffman is the Chief Executive Officer of CytoDyn Inc., based in United States.
- What company does Robert E. Hoffman lead?
- Robert E. Hoffman is CEO of CytoDyn Inc..